ABBV-157

ABBV-157 is a small molecule inhibitor of RoRγT being investigated for the treatment of immune-mediated diseases (e.g. Psoriasis).

Type of Molecule

Small Molecule

Target

RoRγT

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Immune-mediated Diseases n/a
Phase 1